Professor Miroslav Tedla, MD, MPH, PhD is a Chairman of the Department of ORL- HNS at the Faculty of Medicine and University Hospital of the Comenius University in Bratislava, Slovakia.  He is a member of several international societies, CORLAS member and at the moment serves as a Treasurer of European Laryngological Society and the President Elect of  the Confederation of European ORL- HNS.

Dr. Tedla is a main author of three textbooks, author/co-author of more than 130 in extenso scientific papers/book chapters and is regularly invited to present at the international venues. His main clinical and research interests include Thyroid and Paratyhyroid Surgery, Head and Neck Cancer, Voice, Airway and Dysphagia. 

     Gregory W. Randolph MD FACS FACE MAMSE FEBS (Endocrine) FRCEd (ad hominem)  is a Professor of Otolaryngology Head and Neck Surgery and the inaugural Claire and John Bertucci Endowed Chair in Thyroid Surgical Oncology at Harvard Medical School in the Department of Otolaryngology Head and Neck Surgery and Surgeon at Massachusetts Eye & Ear Infirmary. He trained at Cornell and Harvard Medical Schools. He founded and directed the Division of Thyroid and Parathyroid Endocrine Surgery. Dr. Randolph has a thyroid and parathyroid surgical practice focused on thyroid cancer, benign thyroid surgery and hyperparathyroidism exclusively and sees patients and operating at both Mass Eye and Ear Infirmary and Mass General Hospital. He has started the first otolaryngology head and neck surgery endocrine surgery fellowship through the American Head and Neck Society now in its 20th year.

     Dr. Randolph has focused the bulk of his research on recurrent laryngeal nerve anatomy, preservation, and monitoring during thyroid cancer surgery with focus on importance of laryngeal exam, recognition of lymph node metastasis and revision cancer surgery with 340 peer reviewed publications, 170 chapters and 10 books. He has lead thyroid surgical missions to thyroid surgical units in St. Petersburg, Russia, Guangzhou, China, Kenya, rural India and in the Chernobyl region of the Ukraine.  He founded and directs the Harvard Thyroid and Parathyroid Surgery Course for surgeons and has directed international surgical courses. He has received board certification from the European Union’s Board of Surgery in Neck Endocrine Surgery. He has published an endocrine surgical text:  “Surgery of the Thyroid and Parathyroid Glands” published by Elsevier Saunders now in its third edition as well as a text centered on surgery of the recurrent laryngeal nerve “The Recurrent and Superior Laryngeal Nerves” published by Springer Publishers now anticipating its second edition.  He is currently the PI on a funded clinical trial studying the use of neoadjuvant Lenvatinib in surgery for advanced thyroid cancer (NCT04321954).

     He served as President and Director of International Affairs for the American Academy of Otolaryngology Head and Neck Surgery. As of 2024 Dr. Randolph has received the highest honor from the American Academy of Otolaryngology Head and Neck Surgery- he was inducted into the Hall of Distinction and as such is designated by the Academy as a “living legend” of otolaryngology head and neck surgery. He has served as chair of the Endocrine Surgery Section of the American Head and Neck Society and currently is the Chair of the Administration Division of the American Head and Neck Society and has served on the Board of Directors, Surgical Liaison for the American Association of Clinical Endocrinology. He has been inducted into the ACS Master Surgeon Educators Academy (MAMSE designation). Currently he is otolaryngology chair of the American Board of Otolaryngology Focus Practice Designation for thyroid surgery Work group and also the President of the World Congress on Thyroid Cancer and the  International Thyroid Oncology Group, an advanced cancer clinical trials group of endocrinologists, medical oncologists, and surgeons.

Anastasios Maniakas, M.D., PhD., is an Associate Professor, Tenure Track, in the Department of Head and Neck Surgery at The University of Texas MD Anderson Cancer Center. Dr. Maniakas received his undergraduate, master’s, and doctoral degrees from McGill University, and his medical doctorate from the University of Montreal. He completed his residency at the University of Montreal followed by a fellowship in head and neck surgical oncology at The University of Texas MD Anderson Cancer Center. His clinical expertise is in head and neck cancers, with an emphasis on thyroid disease, oral cavity cancer, skin cancers, and salivary gland neoplasms. Dr. Maniakas’ research interests focus on translational research, developing unique patient-derived xenograft models utilized in understanding cancer pathogenesis and novel drug therapy development. Furthermore, Dr. Maniakas is investigating the effect of the microbiome in the development, progression, and recurrence of cancer in his patient population. Lastly, he is leading a global randomized trial evaluating the effect of photoimmunotherapy in locoregionally advanced head and neck squamous cell carcinoma.

Prof. Kursat GOKCAN, M.D. was graduated from Ankara University Medical School Otolaryngology Head and Neck Surgery Program in 2004 and working as a clinical professor at the same institution since 2016. His main areas of interest are thyroid- parathyroid surgery; head and neck cancer surgery; transoral larynx cancer surgery; voice, restoration of airway in bilateral abductor vocal fold paralysis and computational fluid dynamics experiments on airway.